Terumo (MEX:4543N) Cyclically Adjusted Revenue per Share: MXN58.69 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4543N Terumo Corp MEX:4543N
86 GF Score
Price MXN261.28
GF Value MXN349.37
View Full Analysis

What is Terumo Cyclically Adjusted Revenue per Share?

Terumo MEX:4543N 86 Cyclically Adjusted Revenue per Share is MXN58.69 as of Mar. 2026. GuruFocus rates MEX:4543N with a GF Score™ of 86/100 and a GF Value™ of MXN349.37.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Terumo's adjusted revenue per share for the three months ended in Mar. 2026 was MXN23.132. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN58.69 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Terumo's average Cyclically Adjusted Revenue Growth Rate was 9.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Terumo was 10.40% per year. The lowest was 6.20% per year. And the median was 7.30% per year.

As of today (2026-08-09), Terumo's current stock price is MXN261.28. Terumo's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MXN58.69. Terumo's Cyclically Adjusted PS Ratio of today is 4.45.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Terumo was 7.83. The lowest was 3.51. And the median was 5.34.


Terumo  (MEX:4543N) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Terumo's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=261.28/58.69
=4.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Terumo was 7.83. The lowest was 3.51. And the median was 5.34.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Terumo Cyclically Adjusted Revenue per Share Related Terms


Terumo Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Terumo's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo Cyclically Adjusted Revenue per Share Chart

Terumo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.91 56.01 42.79 69.96 58.69

Terumo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.96 68.53 75.90 84.03 58.69

MEX:4543N vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Terumo's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Terumo Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Terumo's Cyclically Adjusted PS Ratio falls into.


MEX:4543N
86GF Score
Terumo Corp MEX:4543N
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Terumo Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Terumo's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=23.132/112.7000*112.7000
=23.132

Current CPI (Mar. 2026) = 112.7000.

Terumo Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 14.048 98.100 16.139
201609 14.716 98.000 16.923
201612 14.766 98.400 16.912
201703 15.307 98.100 17.585
201706 15.017 98.500 17.182
201709 15.743 98.800 17.958
201712 17.519 99.400 19.863
201803 17.067 99.200 19.390
201806 16.830 99.200 19.120
201809 15.574 99.900 17.569
201812 18.348 99.700 20.740
201903 17.971 99.700 20.314
201906 17.919 99.800 20.235
201909 18.748 100.100 21.108
201912 18.591 100.500 20.848
202003 22.846 100.300 25.670
202006 18.610 99.900 20.994
202009 21.009 99.900 23.701
202012 20.938 99.300 23.763
202103 20.529 99.900 23.159
202106 20.515 99.500 23.237
202109 21.328 100.100 24.013
202112 21.298 100.100 23.979
202203 19.948 101.100 22.237
202206 19.583 101.800 21.680
202209 19.154 103.100 20.937
202212 20.756 104.100 22.471
202303 18.304 104.400 19.759
202306 17.523 105.200 18.772
202309 18.079 106.200 19.186
202312 18.936 106.800 19.982
202403 17.817 107.200 18.731
202406 20.176 108.200 21.015
202409 23.231 108.900 24.042
202412 24.099 110.700 24.534
202503 24.461 111.100 24.813
202506 22.962 111.700 23.168
202509 23.122 112.000 23.267
202512 23.224 113.000 23.162
202603 23.132 112.700 23.132

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN58.69 mean?
Terumo (MEX:4543N) has a Cyclically Adjusted Revenue per Share of MXN58.69 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Terumo and its competitors.
Is Terumo's Cyclically Adjusted Revenue per Share too high?
Terumo's current Cyclically Adjusted Revenue per Share is MXN58.69. Overall, Terumo has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Terumo's Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
Terumo's Cyclically Adjusted Revenue per Share of MXN58.69 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Terumo and its competitors. Terumo's current Cyclically Adjusted Revenue per Share is MXN58.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Terumo (MEX:4543N) has a current Cyclically Adjusted Revenue per Share of MXN58.69. The stock's GF Value™ is MXN349.37, compared to a current price of MXN261.28 — trading 25.2% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN58.69. Terumo's overall GF Score™ is 86/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Terumo (MEX:4543N), the current Cyclically Adjusted Revenue per Share is MXN58.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Terumo (MEX:4543N) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of MXN261.28 is trading 25.2% below its estimated GF Value™ of MXN349.37.

Key valuation signals for MEX:4543N:

  • Cyclically Adjusted Revenue per Share: MXN58.69
  • GF Value™: MXN349.37 vs. price of MXN261.28 (25.2% below fair value)
  • GF Score™: 86/100

No single metric tells the full story. See the MEX:4543N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
86GF Score

Get the complete analysis for MEX:4543N

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN261.28
Price
MXN349.37
GF Value